inhaled insulin Afrezza powder
Selected indexed studies
- Recommendations for Initiating Use of Afrezza Inhaled Insulin in Individuals with Type 1 Diabetes. (Diabetes Technol Ther, 2018) [PMID:29901406]
- AFREZZA® (insulin human) Inhalation Powder: A Review in Diabetes Mellitus. (Drugs, 2015) [PMID:26384673]
- Afrezza: An inhaled approach to insulin delivery. (J Am Assoc Nurse Pract, 2015) [PMID:25764151]
_Worker-drafted node — pending editorial review._
Connections
inhaled insulin Afrezza powder is a side effect of
Sources
- Recommendations for Initiating Use of Afrezza Inhaled Insulin in Individuals with Type 1 Diabetes. (2018) pubmed
- Afrezza: An inhaled approach to insulin delivery. (2015) pubmed
- Technosphere insulin: inhaled prandial insulin. (2016) pubmed
- AFREZZA® (insulin human) Inhalation Powder: A Review in Diabetes Mellitus. (2015) pubmed
- Long-Term Nonclinical Pulmonary Safety Assessment of Afrezza, a Novel Insulin Inhalation Powder. (2021) pubmed
- A second-generation inhaled insulin for diabetes mellitus. (2015) pubmed
- Afrezza (Insulin Human) Inhalation Powder: A New Inhaled Insulin for the Management Of Type-1 or Type-2 Diabetes Mellitus. (2015) pubmed
- Technosphere insulin: an inhaled prandial insulin product. (2010) pubmed
- Place of technosphere inhaled insulin in treatment of diabetes. (2016) pubmed
- Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats. (2020) pubmed